Nomination Committee appointed for SciBase Holding's Annual General Meeting in 2027

Resumen detallado
The following people have been appointed as members of SciBase Holding's nominating committee for the Annual General Meeting in 2027: ...
STOCKHOLM, Nov. 19, 2026 /PRNewswire/ -- The following people have been appointed as members of SciBase Holding's nominating committee for the Annual General Meeting in 2027:
Anders Bladh (Ribbskottet AB),Derek Maetzold (Castle Biosciences Inc)Maria Anderkvist (Coeli Wealth Management),Jesper Høiland (Chairman of the Board).
The appointments have been made in accordance with the instructions regarding principles for the appointment of the company nominating committee which were determined at the Annual General Meeting of SciBase Holding on May 19, 2026.
The Annual General Meeting of SciBase Holding AB (publ) will be held on May 20, 2027 in Stockholm.
Shareholders who wish to have an item considered by the nominating committee can do this in writing to SciBase Holding AB (publ), Att: Chairman of the Board, Box 3337, 103 67 Stockholm or by e-mail to info@scibase.com Att: Chairman of the Board (who is the convenor of the nominating committee).
Shareholders who wish to have an item considered at the Annual General Meeting can submit a request to the Board to this effect. Such a request for an item to be considered is to be sent to SciBase Holding AB (publ), Att: Chairman of the Board, Box 3337, 103 67 Stockholm, and must have been received by the Board no later than seven weeks before the Annual General Meeting, or otherwise in such good time that the matter, where necessary, can be included in the notice to attend the Annual General Meeting.
For more information, please contact:Jesper Høiland, Chairman of the board, phone +45 612 207 30Michael Colérus, CFO, phone +46 70 341 34 72
Certified Advisor (CA): DNB Carnegie Investment Bank AB (publ) Phone: +46 8 588 68 570,
SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops, manufactures, and commercializes Nevisense, a unique point-of-care platform that combines AI and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health…
Inicio del artículo, extracto de Yahoo Finance. Para leer el resto, abra el artículo en el sitio del medio.
MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (finance.yahoo.com)




